ANDA 76475, held by Chartwell RX. Acetaminophen; Tramadol Hydrochloride.
As of Nov 21, 2026, ANDA 76475 (Tramadol Hydrochloride and Acetaminophen), held by Chartwell RX, was first approved by FDA on Apr 21, 2005, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 21, 2005 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Tramadol Hydrochloride and Acetaminophen325MG;37.5MG ยท tablet;oral | Acetaminophen; Tramadol Hydrochloride | Discontinued |
| Dec 29, 2025 | Supplement 25Labeling ยท Standard review | Approved | None posted |
| Dec 15, 2023 | Supplement 24Labeling ยท Standard review | Approved | None posted |
| Sep 18, 2018 | Supplement 19REMS | Approved | None posted |
| Jun 20, 2016 | Supplement 16Labeling ยท Standard review | Approved | None posted |
| Aug 1, 2014 | Supplement 15Labeling ยท Standard review | Approved | None posted |
| Oct 31, 2011 | Supplement 14Labeling | Approved | None posted |
| Oct 11, 2011 | Supplement 12Labeling | Approved | None posted |
| Mar 25, 2011 | Supplement 10Labeling | Approved | None posted |
| Jan 12, 2007 | Supplement 5Labeling | Approved | None posted |
| Apr 21, 2005 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. โWhat FDA's review saysโ is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters